Red blood cell distribution width-to-monocyte ratio for predicting 90-day mortality of COVID-19 in patients with chronic kidney disease during the Omicron period: a prospective single-center study-Reference-Cited by-同舟云学术

Red blood cell distribution width-to-monocyte ratio for predicting 90-day mortality of COVID-19 in patients with chronic kidney disease during the Omicron period: a prospective single-center study

Published:2024-08-23 Issue:2 Volume:46 Page:
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Li Chaofan¹^ORCID,Niu Yue¹,Chen Dinghua¹,Feng Zhe¹,Liu Fei²,Wang Yong¹,Cao Xueying¹,Wu Jie¹,Liu Jiabao¹,Sun Xuefeng¹,Zhang Li¹,Cai Guangyan¹^ORCID,Li Ping¹^ORCID,Chen Xiangmei¹^ORCID

Affiliation:

1. Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China

2. Department of Urology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Funder

National Key Research and Development Program of China

Beijing Municipal Sciences and Technology Commission of China

National Natural Science Foundation of China

Young Elite Scientists Sponsorship Program by the China Association for Science and Technology

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2024.2387933

Reference35 articles.

1. Clinical management of COVID-19: living guideline 13 January 2023. Geneva: World Health Organization; 2023 (WHO/2019-nCoV/clinical/2023.1).

2. COVID19 biomarkers: What did we learn from systematic reviews?

3. COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters

4. Red Cell Distribution Width and Mortality in Hemodialysis Patients